Late 2017 HIV Conferences Focus on Antiretrovirals and Comorbidities

Late 2017 HIV Conferences Focus on Antiretrovirals and Comorbidities

1 of 11
Next >

2017 may be winding down, but even as the year wanes, we've seen significant new HIV research featured in major scientific conferences in the U.S. and Europe.

IDWeek, most recently held in San Diego in early October 2017, is an annual infectious diseases conclave with a heavy dose of HIV research. The European AIDS Conference, which took place in Milan in late October 2017, features HIV research and is held every two years. Both meetings are attended by some of the world's top HIV clinicians and scientists.

Here are brief summaries of 10 key studies presented at these two meetings. Many of these key studies focused on antiretroviral switch strategies, HIV drugs in development, or comorbidities in people living with HIV.

Image Credit: Carlos Del Rio, M.D., addresses attendees at last year's IDWeek conference (Credit Myles Helfand)

2017 may be winding down, but even as the year wanes, we've seen significant new HIV research featured in major scientific conferences in the U.S. and Europe.

IDWeek, most recently held in San Diego in early October 2017, is an annual infectious diseases conclave with a heavy dose of HIV research. The European AIDS Conference, which took place in Milan in late October 2017, features HIV research and is held every two years. Both meetings are attended by some of the world's top HIV clinicians and scientists.

Here are brief summaries of 10 key studies presented at these two meetings. Many of these key studies focused on antiretroviral switch strategies, HIV drugs in development, or comorbidities in people living with HIV.

Image Credit: Carlos Del Rio, M.D., addresses attendees at last year's IDWeek conference (Credit Myles Helfand)